Acute respiratory viral infections: Topical issues of diagnosis, prevention and treatment in therapeutic practice

Close metadata

Recommended articles:

Dynamics of the spectrum of genotypes of Listeria monocytogenes, which caused invasive listeriosis during the period of circulation of sars-cov-2 Omicron variants. Molecular Genetics, Microbiology and Virology. 2024;(3):29-36

A rational approach to the prevention and treatment of ARVI and influenza, as a medico-economic and socially significant problem of the XXI century. Journal of Respiratory Medicine. 2025;(1):43-48

Acute bronchitis: to treat or not to treat?. Journal of Respiratory Medicine. 2025;(1):49-57

Post-exposure prophylaxis of influenza and ARVI. Results of a double-blind, placebo-controlled clinical trial of Meglumine acridone acetate and its pharmacoeconomic rationale. Russian Journal of Preventive Medicine. 2025;(4):57-66

Objective: to assess the efficacy and safety of the medication Grippferon with loratadine for the prevention of acute respiratory viral infections (ARVI) and influenza during the epidemics. Materials and methods: This study included 103 patients (67 men and 36 women) aged 18 to 52 years (mean age 35.3±3.2 years). During the first visit (september 2015), we collected patient history data on the average rate of ARVI and influenza for the past three years, the disease duration and its symptoms, presence of concomitant allergic pathologies (such as vasomotor rhinitis, hay fever and urticaria) and food allergies. Appropriate recommendations for the medication use were given to patients. During the second visit (may 2016), we collected follow-up cards and then analyzed the findings. Results: 33 percent of the patients were fully compliant with the medication dosage regimen. In the first group (68 people with a history of one-two ARVI cases in the autumn-winter period for the past three years) the average number of ARVI cases in previous years was 1,53±0,23, by comparing with 0,69±0,16 (p<0.01) during the follow-up period, when medication Grippferon with loratadine was used. No ARVI cases were noted in 21 patients. In the second group (35 people with a history of three or more ARVI cases for the past three years) the average number of ARVI cases in previous years was 3,69±0,29, by comparing with 2,49±0,22 (p<0.05) during the follow-up period, when nasal ointment Grippferon with loratadine was applied. Two people reported that they did not have ARVI. We noted a positive ARVI symptoms dynamics in patients, who received treatment with the given medication. Specifically, a reduced duration of fever and intoxication periods as well as decreased catarrhal symptoms in the nasopharynx and oropharynx were observed. Conclusion. The results of our study allow us to consider a new combined medication Grippferon with loratadine (nasal ointment) as an effective and safe medication for the prevention and treatment of influenza and acute respiratory viral infections in the complex therapy in adult patients, including patients with allergic history.

Keywords:

acute respiratory viral infections

influenza

therapist

interferon

Grippferon

Grippferon with loratadine

Authors:

Trukhan D.I.

Omsk State Medical University» Ministry of Health of Russia, Omsk, Russia

Mazurov A.L.

V.P. Vykhodtsev, Omsk Clinical Ophthalmological Hospital, Omsk, Russia

Rechapova L.A.

Omsk City Clinical Hospital №1, Omsk, Russia

List of references:

WHO materials. Accessed August 12, 2016. Available at: http://www.who.int/mediacentre/factsheets/fs211/ru/
Malyi V, Romantsov M, Sologub T. Gripp. Posobie dlya vrachei. SPb.-Khar'kov; 2007. (In Russ.) Accessed August 12, 2016. Available at: http://medi.ru/doc/a210207.htm
Sologub T, Osinovets O. Immunomodulyatory v kompleksnoi terapii ORVI: vozmozhnosti primeneniya preparata galavit. Russkii meditsinskii zhurnal. 2013;3. (In Russ.) Accessed August 12, 2016. Available at: http://www.rmj.ru/articles_8613.htm
Infektsionnye bolezni: natsional'noe rukovodstvo. Pod obshch. red. Yushchuka N, Vengerova Yu. M.: Geotar-Med.; 2009. (In Russ.)
Ershov F, Kas'yanova N. Sovremennye printsipy profilaktiki i lecheniya grippa i ORVI. Consilium medicum. 2004;1:1-13. (In Russ.)
Afanas'eva I. Giporamin v lechenii ORVI u detei. Russkii meditsinskii zhurnal. 2005;21:1404-1405. (In Russ.)
Ershova A. Kompleksnyi podkhod k lecheniyu ostrykh respiratornykh virusnykh zabolevanii. Russkii meditsinskii zhurnal. 2011;18. Accessed August 12, 2016. (In Russ.) Available at: http://rmj.ru/articles_7807.htm
Romantsov M, Kiselev O, Sologub T. Etiopatogeneticheskaya farmakoterapiya ORVI i grippa. Lechashchii vrach. 2011;2:92-96. (In Russ.)
Tarasova L, Trukhan D. Ostrye respiratorno-virusnye infektsii v praktike vracha pervogo kontakta: osobennosti kliniki, profilaktiki i reabilitatsii. Spravochnik poliklinicheskogo vracha. 2013;7-8:29-32. (In Russ.)
Trukhan D, Tarasova L. Osobennosti kliniki i lecheniya ostrykh respiratornykh virusnykh infektsii v praktike vracha-terapevta. Vrach. 2014;8:44-47. (In Russ.)
Trukhan D. ORVI v praktike terapevta. Uchastkovyi terapevt. 2015;5:5. (In Russ.)
Malyshev N, Kolobukhina L, Merkulova L, Ershov F. Sovremennye podkhody k povysheniyu effektivnosti terapii i profilaktiki grippa i drugikh ostrykh respiratornykh virusnykh infektsii. Consilium medicum. 2005;10:831-835. (In Russ.)
Lytkina I, Malyshev N. Profilaktika i lechenie grippa i ostrykh respiratornykh virusnykh infektsii sredi epidemiologicheski znachimykh grupp naseleniya. Lechashchii vrach. 2010;10:66-69. (In Russ.)
Ostrye respiratornye zabolevaniya u detei: lechenie i profilaktika. Nauchno-prakticheskaya programma Soyuza pediatrov Rossii. M.: Mezhdunarodnyi Fond okhrany zdorov'ya materi i rebenka; 2002. (In Russ.)
Ostrye respiratornye virusnye infektsii v ambulatornoi praktike vracha-pediatra. Posobie dlya vrachei pod red. Korovinoi N. M.; 2004. (In Russ.)
Ershov F. Interferony i ikh induktory (ot molekul do lekarstv). F.I. Ershov, O.I. Kiselev. M.: «GEOTAR—Media»; 2005. (In Russ.)
Gaponyuk P, Korovkin S. Grippferon kapli v nos: Profilaktika i lechenie grippa i ostrykh respiratornykh virusnykh infektsii. M.; 2004. (In Russ.)
Feklisova L, Shebekova V, Tselipanova E. i soavt. Grippferon u detei, bol'nykh ORVI. Vrach. 2001;3:40-41. (In Russ.)
Kramarev S, Buts A, Chemerkina N. Otsenka effektivnosti Grippferona, kapel' v nos v profilaktike i lechenii grippa i drugikh ostrykh respiratornykh virusnykh infektsii u detei. Apteka. 2002;5:4. (In Russ.)
Lytkina I, Ezhlova E, Filatov N. i soavt. Opyt primeneniya preparata «Grippferon» dlya profilaktiki ostrykh respiratornykh infektsii v detskikh doshkol'nykh uchrezhdeniyakh. Materialy VIII s»ezda Vserossiiskogo obshchestva epidemiologov, mikrobiologov i parazitologov. M.; 2002:64-65. (In Russ.)
Bolotova N, Eliseev Yu, Grozdova T. Opyt ispol'zovaniya preparata «Grippferon — kapli v nos» dlya lecheniya ORVI u detei pervogo goda zhizni. Voprosy sovremennoi pediatrii: materialy nauchno-prakticheskoi konferentsii pediatrov Rossii «Farmakoterapiya v pediatrii». M.; 2003.T.2;2:32. (In Russ.)
Zaplatnikov A. Immunoprofilaktika i immunoterapiya ostrykh respiratornykh infektsii u detei. Russkii meditsinskii zhurnal. 2006;9:50-56. (In Russ.)
Ermilova N, Radtsig E, Bogomil'skii M i soavt. Profilaktika ORVI v organizovannykh detskikh kollektivakh: sposoby i effektivnost'. Voprosy sovremennoi pediatrii. 2012;1:98-102. (In Russ.)
Vasil'eva T, Chumakov A. Grippferon: ot eksperimental'nykh issledovanii do prakticheskogo ispol'zovaniya. Infektsionnye bolezni: novosti, mneniya, obuchenie. 2013;2(3):124-131. (In Russ.)
Fil'kina O, Vasil'eva T. Antimikrobnaya terapiya v kompleksnom lechenii ORVI u nedonoshennykh detei na pervom godu zhizni. Prakticheskaya meditsina. 2014;7:170-172. (In Russ.)
Fil'kina O, Pykhtina L, Kocherova O, Vorob'eva E. Kombinirovannaya mediko-psikhologicheskaya profilaktika ostrykh respiratornykh virusnykh infektsii u chasto boleyushchikh detei s primeneniem topicheskikh interferonov. Effektivnaya farmakoterapiya. 2015;15:12-16. (In Russ.)
Osidak L, Yanina M, Zarubaev V i dr. profilaktika adenovirusnoi infektsii v detskikh doshkol'nykh uchrezhdeniyakh s pomoshch'yu preparata rekombinantnogo interferona al'fa-2b. Detskie infektsii. 2016;2:9-14. (In Russ.)
Shumilov V. Gripp i ORVI: nespetsificheskaya profilaktika s ispol'zovaniem gennoinzhenernogo α2-interferona i ego novykh form. Lechashchii vrach. 2000;9:20-21. (In Russ.)
Osidak L, Drinevskii V, Gaponyuk P. Grippferon. Metodicheskoe posobie dlya vrachei. SPb.: GU Nauchno-issledovatel'skii institut grippa RAMN; 2008. (In Russ.)
Doroshenko E, Gaponyuk P. Rol' rossiiskogo preparata Grippferon v lechenii i profilaktike grippa i drugikh ORVI. Poliklinika. 2008;5:22-26. (In Russ.)
Osidak L, Drinevskii V, Obraztsova E. Grippferon kak sredstvo lecheniya i profilaktiki grippa. Terra Medica Nova. 2009;1:12-16. (In Russ.)
Loginova S, Borisevich S, Shchukina V i soavt. Eksperimental'noe izuchenie protivovirusnoi aktivnosti preparata «Grippferon» v otnoshenii «meksikanskogo» pandemicheskogo virusa grippa A/H1N1/2009 in vitro. Antibiotiki i khimioterapiya. 2011;5:7-10. (In Russ.)
Belokrinitskaya T, Liga V, Trubitsyna A, Tarbaeva D. Medikamentoznaya profilaktika grippa u beremennykh. Voprosy ginekologii, akusherstva i perinatologii. 2012;4:31-36. (In Russ.)
Belokrinitskaya T, Trubitsyna A, Koshmeleva E. Akusherskie i perinatal'nye iskhody pri oslozhnennykh formakh grippa A (H1N1) u beremennykh. Zhurnal akusherstva i zhenskikh boleznei. 2011;5:94-98. (In Russ.)
Skoner DP, Gentile DA, Fireman P et al. Urinary histamine metabolite elevations during experimental influenza infection. Ann Allergy Asthma Immunol. 2001;87(4):303-306.
Skoner DP. Viral infection and allergy: lower airway. Allergy Asthma Proc. 2002;23(4):229-232.
Fedoskova T. Osobennosti lecheniya ORVI u bol'nykh kruglogodichnym allergicheskim rinitom. Rossiiskii allergologicheskii zhurnal. 2010;5:100-105. (In Russ.)
Gentile DA, Skoner DP. Viral rhinitis. Curr Allergy Asthma Rep. 2001;1(3):227-234.
Kuznetsova O, Pleshanova Zh. Mesto sovremennykh kombinirovannykh preparatov v lechenii ostrykh respiratorno-virusnykh infektsii v ambulatornoi praktike. Consilium Medicum. 2010;3:93-102. (In Russ.)
Surov A, Zaspina A. Opyt primeneniya lekarstvennogo preparata interferon al'fa-2b v sochetanii s loratadinom v vide gelya dlya mestnogo i naruzhnogo primeneniya v kompleksnoi terapii allergicheskikh zabolevanii glaz. Oftal'mologiya. 2014;1:62-65. (In Russ.)
Trukhan D, Lebedev O. Izmenenie organa zreniya pri somaticheskikh zabolevaniyakh. Terapevticheskii arkhiv. 2015;8:132-136 (In Russ.)
Sotnikova N, Pakhomova T, Lykova T. Lechebnaya effektivnost' kombinirovannogo lekarstvennogo preparata Allergoferon pri persistiruyushchem allergicheskom rinite. Rossiiskii allergologicheskii zhurnal. 2016;1:52-6. (In Russ.)
Ushakova S, Talaev A, Chumikov O, Moiseenkov D. Otsenka effektivnosti i bezopasnosti preparata grippferon s loratadinom v profilaktike grippa i drugikh ostrykh respiratornykh virusnykh infektsii. Vrach. 2015;11:72-76. (In Russ.)
Gaponyuk P. Novyy podkhod k lecheniyu bolnykh s allergicheskim rinitom. Allergologiya i immunologiya. 2008;9(3). (In Russ.)

Close metadata